NCT06173336

Brief Summary

Gastroparesis is a chronic disease of the stomach that causes delayed gastric emptying without stenosis. The clinical symptoms of gastroparesis include nausea, vomiting, early satiety, post-prandial fullness, bloating, belching, and upper abdominal discomfort Gastroparesis cardinal symptoms index (GCSI) is a reliable, reproducible, and valid instrument for measuring symptom severity in patients with gastroparesis. This will be a randomized controlled trial of all the patients who are referred to the University of Arkansas Medical Sciences (UAMS) for gastric peroral endoscopic pyloromyotomy (G-POEM) for treatment of refractory and severe gastroparesis. During G-POEM procedure, either single or double pyloromyotomy will be performed with randomization. The aim is to compare clinical outcomes and the efficacy of single versus double pyloromyotomy in G-POEM for refractory and severe gastroparesis.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2025

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
1.5 years until next milestone

Study Start

First participant enrolled

June 17, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2025

Completed
Last Updated

June 25, 2025

Status Verified

September 1, 2024

Enrollment Period

Same day

First QC Date

December 7, 2023

Last Update Submit

June 19, 2025

Conditions

Keywords

Gastric Per-Oral Endoscopic Myotomy (G-POEM)

Outcome Measures

Primary Outcomes (3)

  • Clinical success at 3 months, 6 months and 12 months follow up

    Measuring clinical success

    3, 6 and 12 months

  • Gastroparesis Cardinal Symptom Index (GCSI) score before and after GPOEM at 3, 6 months and 12 months follow up

    Measuring GCSI scores

    3, 6 and 12 months

  • Technical success rate

    Measuring technical success

    At time of procedure

Secondary Outcomes (3)

  • Total procedure time for each method

    At time of procedure

  • Adverse events like pneumoperitoneum, gi bleeding, perforation, infection and abdominal pain

    0 and1 month

  • Recurrence of symptoms

    3, 6 and 12 months

Study Arms (2)

Single pyloromyotomy gastric per-oral endoscopic myotomy (G-POEM)

ACTIVE COMPARATOR

Single cut pyloromyotomy technique during gastric per-oral endoscopic myotomy (G-POEM) procedure

Procedure: gastric per-oral endoscopic myotomy (G-POEM)

Double pyloromyotomy gastric per-oral endoscopic myotomy (G-POEM)

ACTIVE COMPARATOR

Double cut pyloromyotomy technique during gastric per-oral endoscopic myotomy (G-POEM) procedure

Procedure: gastric per-oral endoscopic myotomy (G-POEM)

Interventions

Comparing single versus double pyloromyotomy in G-POEM for refractory and severe gastroparesis.

Double pyloromyotomy gastric per-oral endoscopic myotomy (G-POEM)Single pyloromyotomy gastric per-oral endoscopic myotomy (G-POEM)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with refractory (persistent symptoms for \>6 months refractory to medical therapy) and severe gastroparesis based on GCSI \> 2, with confirmed im-paired gastric emptying based on gastric emptying.
  • Persons 18 years or older at the time of signing the informed consent

You may not qualify if:

  • No previous attempt with at least one prokinetic drug.
  • Previous gastric surgery.
  • Esophageal or gastric varices and /or portal gastropathy.
  • Pregnant patients.
  • Malignant or pre-malignant gastric diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (11)

  • Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009 Apr;136(4):1225-33. doi: 10.1053/j.gastro.2008.12.047. Epub 2008 Dec 24.

  • Verga MC, Mazza S, Azzolini F, Cereatti F, Conti CB, Drago A, Soro S, Elvo B, Grassia R. Gastric per-oral endoscopic myotomy: Indications, technique, results and comparison with surgical approach. World J Gastrointest Surg. 2022 Jan 27;14(1):12-23. doi: 10.4240/wjgs.v14.i1.12.

  • Camilleri M, Chedid V, Ford AC, Haruma K, Horowitz M, Jones KL, Low PA, Park SY, Parkman HP, Stanghellini V. Gastroparesis. Nat Rev Dis Primers. 2018 Nov 1;4(1):41. doi: 10.1038/s41572-018-0038-z.

  • Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004 May;13(4):833-44. doi: 10.1023/B:QURE.0000021689.86296.e4.

  • Lacy BE, Parkman HP, Camilleri M. Chronic nausea and vomiting: evaluation and treatment. Am J Gastroenterol. 2018 May;113(5):647-659. doi: 10.1038/s41395-018-0039-2. Epub 2018 Mar 15.

  • Hirsch W, Nee J, Ballou S, Petersen T, Friedlander D, Lee HN, Cheng V, Lembo A. Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013. J Clin Gastroenterol. 2019 Feb;53(2):109-113. doi: 10.1097/MCG.0000000000000972.

  • Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010 Jan;31(1):11-9. doi: 10.1111/j.1365-2036.2009.04189.x.

  • Ahuja NK, Clarke JO. Pyloric Therapies for Gastroparesis. Curr Treat Options Gastroenterol. 2017 Mar;15(1):230-240. doi: 10.1007/s11938-017-0124-4.

  • Aghaie Meybodi M, Qumseya BJ, Shakoor D, Lobner K, Vosoughi K, Ichkhanian Y, Khashab MA. Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis. Endosc Int Open. 2019 Mar;7(3):E322-E329. doi: 10.1055/a-0812-1458. Epub 2019 Feb 28.

  • Khashab MA, Stein E, Clarke JO, Saxena P, Kumbhari V, Chander Roland B, Kalloo AN, Stavropoulos S, Pasricha P, Inoue H. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2013 Nov;78(5):764-8. doi: 10.1016/j.gie.2013.07.019. No abstract available.

  • Abdelfatah MM, Li B, Kapil N, Noll A, Li L, Luo H, Chen H, Xia L, Chen X, Patel V, Mekaroonkamol P, Massaad J, Keilin S, Cai Q. Short-term outcomes of double versus single pyloromyotomy at peroral endoscopic pyloromyotomy in the treatment of gastroparesis (with video). Gastrointest Endosc. 2020 Sep;92(3):603-609. doi: 10.1016/j.gie.2020.01.016. Epub 2020 Jan 17.

MeSH Terms

Conditions

Gastroparesis

Interventions

Pyloromyotomy

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDigestive System Surgical ProceduresSurgical Procedures, OperativeGastrectomyMyotomy

Study Officials

  • Sumant Inamdar, MD

    University of Arkansas

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2023

First Posted

December 15, 2023

Study Start

June 17, 2025

Primary Completion

June 17, 2025

Study Completion

June 17, 2025

Last Updated

June 25, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share